3 ms·
https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v2 https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v... Note that it is not peer reviewed
by travisporter 7y ago
https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v2 https://www.medrxiv.org/content/10.1101/2020.03.22.20040758v...
Note that it is not peer reviewed
- gus_massa 7y agoThanks for the link, it looks good. This part is strange: > Normalization and mitigation criteria included the following: a. Body temperature ≤ 36.6 °C on the surface, ≤ 37.2 °C under the armpit and mouth or ≤ 37.8 °C in the rectum and tympanic membrane; Is this a standard criteria? Why didn't they agree to use the same measurement method in all the study? The part about counting coughs is not convincing for me, it looks too difficult to measure accurately. I prefer to ignore it. But this part looks really interesting: > Notably, a total of 4 of the 62 patients progressed to severe illness, all of which occurred in the control group not receiving HCQ treatment. For adverse effects, it should be noted that there were two patients with mild adverse reactions in the HCQ treatment group, one patient developed a rash, and one patient experienced a headache, none severe side effects appeared among them.